{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:06:19Z","timestamp":1762430779835,"version":"build-2065373602"},"reference-count":47,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2013,6,18]],"date-time":"2013-06-18T00:00:00Z","timestamp":1371513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Vitamin D is a steroid hormone with a broad range of biological effects ranging from the classical role as a mediator of calcium and phosphate balance to cellular differentiation and immune modulation. These effects impact normal and dysfunctional hematopoietic and immune function, which may allow an avenue for improved treatment and support of patients suffering from hematologic disorders. In this review, we will summarize the role of vitamin D in normal hematopoiesis, discuss ways in which  vitamin D may improve outcomes, and discuss a potential role of vitamin D for treating hematologic disorders and modulating the immune system to improve the outcome of allogeneic stem cell transplant.<\/jats:p>","DOI":"10.3390\/nu5062206","type":"journal-article","created":{"date-parts":[[2013,6,18]],"date-time":"2013-06-18T11:40:45Z","timestamp":1371555645000},"page":"2206-2221","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["The Role of Vitamin D in Hematologic Disease and Stem  Cell Transplantation"],"prefix":"10.3390","volume":"5","author":[{"given":"Aric","family":"Hall","sequence":"first","affiliation":[{"name":"Division of Hematology and Medical Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, WI 53705, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Juckett","sequence":"additional","affiliation":[{"name":"Division of Hematology and Medical Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, WI 53705, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2013,6,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2011.10.026","article-title":"Application of vitamin D and derivatives in hematological malignancies","volume":"319","author":"Kim","year":"2012","journal-title":"Cancer Lett."},{"key":"ref_2","unstructured":"Gardner, D., and Shoback, D. (2011). Greenspan\u2019s Basic and Clinical Endocrinology, McGraw-Hill. [9th ed.]."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.cca.2009.03.043","article-title":"Selective monitoring of vitamin D2 and D3 supplementation with a highly specific 25-hydroxyvitamin D3 immunoassay with negligible cross-reactivity to 25-hydroxyvitamin D2","volume":"404","author":"Li","year":"2009","journal-title":"Clin. Chim. Acta"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1744-313X.2008.00758.x","article-title":"Association of vitamin D receptor polymorphisms with the outcome of allogeneic haematopoietic stem cell transplantation","volume":"35","author":"Middleton","year":"2008","journal-title":"Int. J. Immunogenet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1744-313X.2008.00789.x","article-title":"Development of the hla proficiency testing for central and east europe","volume":"35","author":"Lange","year":"2008","journal-title":"Int. J. Immunogenet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/sj.bmt.1703629","article-title":"Vitamin D receptor gene polymorphism associates with graft-versus-host disease and survival in hla-matched sibling allogeneic bone marrow transplantation","volume":"30","author":"Middleton","year":"2002","journal-title":"Bone Marrow Transplant."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.5588\/ijtld.12.0122","article-title":"Risk and outcome of multidrug-resistant tuberculosis: Vitamin D receptor polymorphisms and serum 25(OH)D","volume":"16","author":"Rathored","year":"2012","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jsbmb.2005.06.017","article-title":"Vitamin D compounds in leukemia","volume":"97","author":"Luong","year":"2005","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1172\/JCI0212392","article-title":"Normal myelopoiesis but abnormal t lymphocyte responses in vitamin D receptor knockout mice","volume":"109","author":"Hisatake","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1182\/blood-2010-04-280552","article-title":"Vitamin D receptor deletion leads to increased hematopoietic stem and progenitor cells residing in the spleen","volume":"116","author":"Jeanson","year":"2010","journal-title":"Blood"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1043-2760(97)00066-0","article-title":"Vitamin D and hematopoiesis","volume":"8","author":"Bunce","year":"1997","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1189\/jlb.71.4.641","article-title":"Physiological levels of 1alpha, 25 dihydroxyvitamin D3 induce the monocytic commitment of CD34+ hematopoietic progenitors","volume":"71","author":"Grande","year":"2002","journal-title":"J. Leukoc. Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"6816","DOI":"10.1038\/sj.onc.1210764","article-title":"Transcriptional control of granulocyte and monocyte development","volume":"26","author":"Friedman","year":"2007","journal-title":"Oncogene"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1182\/blood.V92.2.607","article-title":"Impaired granulocytic differentiation  in vitro in hematopoietic cells lacking retinoic acid receptors alpha1 and gamma","volume":"92","author":"Labrecque","year":"1998","journal-title":"Blood"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.4049\/jimmunol.1002545","article-title":"Epigenetic reduction in invariant nkt cells following in utero vitamin D deficiency in mice","volume":"186","author":"Yu","year":"2011","journal-title":"J. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.4049\/jimmunol.1101519","article-title":"Invariant NKT cell defects in vitamin D receptor knockout mice prevents experimental lung inflammation","volume":"187","author":"Yu","year":"2011","journal-title":"J. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"20834","DOI":"10.1073\/pnas.0808700106","article-title":"Failure of T cell homing, reduced CD4\/CD8alphaalpha intraepithelial lymphocytes, and inflammation in the gut of vitamin D receptor ko mice","volume":"105","author":"Yu","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.leukres.2009.09.010","article-title":"Vitamin D3-driven signals for myeloid cell differentiation\u2014Implications for differentiation therapy","volume":"34","author":"Hughes","year":"2010","journal-title":"Leuk. Res."},{"key":"ref_19","first-page":"1399","article-title":"1,25-dihydroxyvitamin D3: In vivo and in vitro effects on human preleukemic and leukemic cells","volume":"69","author":"Koeffler","year":"1985","journal-title":"Cancer Treat. Rep."},{"key":"ref_20","first-page":"125814","article-title":"Clinical experience using vitamin D and analogs in the treatment of myelodysplasia and acute myeloid leukemia: A review of the literature","volume":"2012","author":"Harrison","year":"2012","journal-title":"Leuk. Res. Treat."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/sj.leu.2404601","article-title":"Treatment of low-risk myelodysplastic syndromes with high-dose daily oral cholecalciferol (2000\u20134000 IU vitamin D(3))","volume":"21","author":"Molnar","year":"2007","journal-title":"Leukemia"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1046\/j.1365-2141.1998.00598.x","article-title":"Vitamin D treatment in myelodysplastic syndromes","volume":"100","author":"Mellibovsky","year":"1998","journal-title":"Br. J. Haematol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.leukres.2005.04.003","article-title":"Vitamin D(2) analog (paricalcitol; zemplar) for treatment of myelodysplastic syndrome","volume":"29","author":"Koeffler","year":"2005","journal-title":"Leuk. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/10428190701713648","article-title":"Phase II study of doxercalciferol for the treatment of myelodysplastic syndrome","volume":"49","author":"Petrich","year":"2008","journal-title":"Leuk. Lymphoma"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ajh.2830380112","article-title":"The effect of 1-hydroxyvitamin D3 for prolongation of leukemic transformation-free survival in myelodysplastic syndromes","volume":"38","author":"Motomura","year":"1991","journal-title":"Am. J. Hematol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0753-3322(91)90104-2","article-title":"Retinoic acid in mono- or combined differentiation therapy of myelodysplasia and acute promyelocytic leukemia","volume":"45","author":"Blazsek","year":"1991","journal-title":"Biomed. Pharmacother."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.3324\/haematol.11262","article-title":"Valproic acid combined with 13-cis retinoic acid and 1,25-dihydroxyvitamin D3 in the treatment of patients with myelodysplastic syndromes","volume":"92","author":"Siitonen","year":"2007","journal-title":"Haematologica"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-2141.2008.07465.x","article-title":"Efficacy of a combination of human recombinant erythropoietin + 13-cis-retinoic acid and dihydroxylated vitamin D3 to improve moderate to severe anaemia in low\/intermediate risk myelodysplastic syndromes","volume":"144","author":"Ferrero","year":"2009","journal-title":"Br. J. Haematol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/0145-2126(95)00156-5","article-title":"Combined differentiating therapy for myelodysplastic syndromes: A phase II study","volume":"20","author":"Ferrero","year":"1996","journal-title":"Leuk. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/ajh.2830410307","article-title":"Treatment of acute myeloid leukemia in the elderly with low-dose cytarabine, hydroxyurea, and calcitriol","volume":"41","author":"Slapak","year":"1992","journal-title":"Am. J. Hematol."},{"key":"ref_31","first-page":"619","article-title":"Differentiating agents + low-dose chemotherapy in the management of old\/poor prognosis patients with acute myeloid leukemia or myelodysplastic syndrome","volume":"89","author":"Ferrero","year":"2004","journal-title":"Haematologica"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1600-0609.1990.tb00470.x","article-title":"Treatment of myelodysplastic syndromes with retinoic acid and 1 alpha-hydroxy-vitamin D3 in combination with low-dose ara-c is not superior to ara-c alone. Results from a randomized study. The scandinavian myelodysplasia group (smg)","volume":"45","author":"Hellstrom","year":"1990","journal-title":"Eur. J. Haematol."},{"key":"ref_33","first-page":"533","article-title":"The induction of apoptosis by a combined 1,25(OH)2D3 analog, EB1089 and TGF-beta1 in NCI-H929 multiple myeloma cells","volume":"20","author":"Park","year":"2002","journal-title":"Int. J. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/excr.1999.4735","article-title":"Cell cycle arrest induced by the vitamin D(3) analog EB1089 in NCI-H929 myeloma cells is associated with induction of the cyclin-dependent kinase inhibitor p27","volume":"254","author":"Park","year":"2000","journal-title":"Exp. Cell Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.1182\/blood.V88.12.4659.bloodjournal88124659","article-title":"Myeloma cell growth arrest, apoptosis, and interleukin-6 receptor modulation induced by EB1089, a vitamin D3 derivative, alone or in association with dexamethasone","volume":"88","author":"Puthier","year":"1996","journal-title":"Blood"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2334-13-22","article-title":"Vitamin D accelerates clinical recovery from tuberculosis: Results of the succinct study [supplementary cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis\u2019","volume":"13","author":"Salahuddin","year":"2013","journal-title":"BMC Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1399-0012.2011.01523.x","article-title":"Impact of vitamin D receptor gene polymorphisms on clinical outcomes of  HLA-matched sibling hematopoietic stem cell transplantation","volume":"26","author":"Cho","year":"2012","journal-title":"Clin. Transplant."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/sj.bmt.1702873","article-title":"Mc1288, a vitamin D analog, prevents acute graft-versus-host disease in rat bone marrow transplantation","volume":"27","author":"Pakkala","year":"2001","journal-title":"Bone Marrow Transplant."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/jbmr.1499","article-title":"Bone density and structure in long-term survivors of pediatric allogeneic hematopoietic stem cell transplantation","volume":"27","author":"Ginsberg","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/ajh.22143","article-title":"High incidence of vitamin D deficiency in patients undergoing allogeneic stem cell transplantation","volume":"86","author":"Joseph","year":"2011","journal-title":"Am. J. Hematol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/bmt.2010.326","article-title":"Vitamin D status among long-term survivors of hematopoietic cell transplantation","volume":"46","author":"Robien","year":"2011","journal-title":"Bone Marrow Transplant."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1365-2141.2012.09131.x","article-title":"Organ-specific management and supportive care in chronic graft-versus-host disease","volume":"158","author":"Dignan","year":"2012","journal-title":"Br. J. Haematol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5144\/1658-3876.2012.1","article-title":"Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation","volume":"5","author":"Majhail","year":"2012","journal-title":"Hematol. Oncol. Stem Cell Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/ejh.12069","article-title":"The proteasome inhibitor bortezomib stimulates osteoblastic differentiation of human osteoblast precursors via upregulation of vitamin D receptor signalling","volume":"90","author":"Kaiser","year":"2013","journal-title":"Eur. J. Haematol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1365-2141.2008.07214.x","article-title":"Prevalence and significance of vitamin D deficiency in multiple myeloma patients","volume":"142","author":"Badros","year":"2008","journal-title":"Br. J. Haematol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ajh.21412","article-title":"Impact of vitamin D deficiency on the clinical presentation and prognosis of patients with newly diagnosed multiple myeloma","volume":"84","author":"Ng","year":"2009","journal-title":"Am. J. Hematol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/ajh.21619","article-title":"Vitamin D status may effect the skeletal complications of multiple myeloma","volume":"85","author":"Diamond","year":"2010","journal-title":"Am. J. Hematol."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/5\/6\/2206\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:47:24Z","timestamp":1760219244000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/5\/6\/2206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,18]]},"references-count":47,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2013,6]]}},"alternative-id":["nu5062206"],"URL":"https:\/\/doi.org\/10.3390\/nu5062206","relation":{},"ISSN":["2072-6643"],"issn-type":[{"type":"electronic","value":"2072-6643"}],"subject":[],"published":{"date-parts":[[2013,6,18]]}}}